TelyRx Holdings Inc.
TELY.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | |||
|---|---|---|---|---|---|
| Revenue | 179.82% | 205.53% | 327.77% | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 179.82% | 205.53% | 327.77% | ||
| Cost of Revenue | 152.57% | 91.35% | 211.65% | ||
| Gross Profit | 206.64% | 299.49% | 618.08% | ||
| SG&A Expenses | 307.61% | 307.95% | 716.73% | ||
| Depreciation & Amortization | 85.29% | 156.13% | 188.89% | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 225.35% | 213.79% | 352.18% | ||
| Operating Income | -3,623.17% | -264.11% | -1,655.56% | ||
| Income Before Tax | -12,205.26% | -159.52% | 83.33% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -12,205.26% | -159.87% | 83.33% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -12,205.26% | -247.03% | 84.80% | ||
| EBIT | -3,623.17% | -264.11% | -1,655.56% | ||
| EBITDA | -1,408.26% | -261.11% | -6,860.15% | ||
| EPS Basic | -11,427.78% | -222.47% | 86.20% | ||
| Normalized Basic EPS | -5,868.18% | -220.64% | -207.96% | ||
| EPS Diluted | -11,427.78% | 58.23% | 86.07% | ||
| Normalized Diluted EPS | -5,868.18% | -220.64% | -207.96% | ||
| Average Basic Shares Outstanding | 5.43% | 7.54% | 10.15% | ||
| Average Diluted Shares Outstanding | 5.43% | 7.54% | 10.15% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||